Biotech Fluidics opens office in Germany

20-Jun-2025
Computer-generated image

Symbolic image

Biotech Fluidics announces its commitment to supporting businesses in Germany and the DACH region with the opening of a new office in Haltern am See, Germany.

With an established presence now in four global locations, this expansion represents an important step in Biotech Fluidics’ journey to strengthen its footprint in the European market.

Dr Fritiof Pontén, CEO of Biotech Fluidics commented “Germany is renowned for its technical expertise, academic excellence, and industrial innovation. Opening our first office in Germany means we can help even more local scientists, businesses, and institutions benefit from Biotech Fluidics expertise, experience, and innovative fluidic solutions. We are delighted to announce that this office will be headed by Dr. Annette Dibowski – a highly respected German lab / life sciences industry professional with over 25 years’ experience. In the DACH region - Annette is well known for her strong organizational and analytical skills, her focus on quality and cost-efficiency, and her ability to implement innovative solutions with lab partners.”

Dr Annette Dibowski added “Having cooperated with Biotech Fluidics over recent years I am excited by the opportunity to increase awareness of our technological portfolio and enhance local support for scientists and engineers in German speaking markets.”

Other news from the department business & finance

Most read news

More news from our other portals